Citation Impact

Citing Papers

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Axial Flux Permanent Magnet Disc Machines: A Review
2019
Design of axial-flux permanent-magnet low-speed machines and performance comparison between radial-flux and axial-flux machines
2005
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Soft corrugated channel with synergistic exclusive discrimination gating for CO2 recognition in gas mixture
2023 StandoutNobel
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
Nitric oxide synthases: regulation and function
2011 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Emerging principles in protease-based drug discovery
2010
Novel therapeutic targets for the treatment of heart failure
2011
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study
2008
Structure-Based Drug Design Strategies in Medicinal Chemistry
2009
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Targeting proteases: successes, failures and future prospects
2006
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
2007
Conformational Properties and Energetic Analysis of Aliskiren in Solution and Receptor Site
2011
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
2009 StandoutNobel
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Extracellular matrix structure
2015 Standout
Role of the renin–angiotensin–aldosterone system in vascular remodeling and inflammation: a clinical review
2006
AT2 receptors: Functional relevance in cardiovascular disease
2008
Artificial intelligence in drug development: present status and future prospects
2018 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Inhibitory activities of baicalin against renin and angiotensin-converting enzyme
2011
The use of click chemistry in the emerging field of catalomics
2010
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
2009 Standout
Molecular Recognition in Chemical and Biological Systems
2015
Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide
2006
Ace revisited: A new target for structure-based drug design
2003
Functional Diversity of AAA+ Protease Complexes in Bacillus subtilis
2017 StandoutNobel
The Pathobiology of Vascular Dementia
2013 Standout
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
2020 Standout
Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors
2007
Efficient Assembly of Iminodicarboxamides by a “Truly” Four‐Component Reaction
2012
Novel therapies blocking the renin–angiotensin–aldosterone system in the management of hypertension and related disorders
2006
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Sustainable urban rail systems: Strategies and technologies for optimal management of regenerative braking energy
2013 Standout
Dual Inhibitors for Aspartic Proteases HIV-1 PR and Renin: Advancements in AIDS–Hypertension–Diabetes Linkage via Molecular Dynamics, Inhibition Assays, and Binding Free Energy Calculations
2012
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Attenuation of Brain Damage and Cognitive Impairment by Direct Renin Inhibition in Mice With Chronic Cerebral Hypoperfusion
2011
Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy
2009
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
Review: Update on Newer Antihypertensive Medicines and Interventions
2010
Flywheel energy and power storage systems
2005
Electrical Machines and Drives for Electric, Hybrid, and Fuel Cell Vehicles
2007 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Applications of oxazolidinones as chiral auxiliaries in the asymmetric alkylation reaction applied to total synthesis
2016
Recent advances in the synthesis of pyrroles by multicomponent reactions
2014 Standout
Review of electrical energy storage technologies, materials and systems: challenges and prospects for large-scale grid storage
2018 Standout
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats
2005
Multicomponent reactions: advanced tools for sustainable organic synthesis
2014 Standout
Innovative inverter topology for concentrated winding PM motor drives
2003
A review of energy storage technologies for wind power applications
2012 Standout
Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients
2005
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Overview of different wind generator systems and their comparisons
2008 Standout
Sunflower trypsin inhibitor (SFTI-1) analogues of synthetic and biological origin via N→S acyl transfer: potential inhibitors of human Kallikrein-5 (KLK5)
2014 StandoutNobel
Protection From Ischemic Heart Injury by a Vigilant Heme Oxygenase-1 Plasmid System
2004
Mechanisms of Diabetic Complications
2013 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Renin Inhibitor Aliskiren Improves Impaired Nitric Oxide Bioavailability and Protects Against Atherosclerotic Changes
2008
Direct Renin Inhibitors as a New Therapy for Hypertension
2010
Axial flux machines drives: a new viable solution for electric cars
1997
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement
2009
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
2007 ESH‐ESC Guidelines for the management of arterial hypertension
2007
A systems approach to reduce urban rail energy consumption
2014 Standout
Electrical energy storage systems: A comparative life cycle cost analysis
2014 Standout
Direct renin inhibition: An update
2009
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
Fractional-Slot Concentrated-Windings Synchronous Permanent Magnet Machines: Opportunities and Challenges
2009 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Metal-Free Multicomponent Syntheses of Pyridines
2014 Standout
Solar Energy Supply and Storage for the Legacy and Nonlegacy Worlds
2010 Standout

Works of C. Jensen being referenced

Aliskiren: the first renin inhibitor for clinical treatment
2008
Blood Pressure Lowering in Essential Hypertension With an Oral Renin Inhibitor, Aliskiren
2003
Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100)
2002
A low-loss permanent-magnet brushless DC motor utilizing tape wound amorphous iron
1992
Aliskiren Reduces Blood Pressure and Suppresses Plasma Renin Activity in Combination With a Thiazide Diuretic, an Angiotensin-Converting Enzyme Inhibitor, or an Angiotensin Receptor Blocker
2006
Rankless by CCL
2026